Join Tom and Mike as they share an important update on Tom's prostate cancer journey. In this video, they discuss Tom's ...

Mr. Green, a 50-something businessman was asking a question I find myself answering on a surprisingly regular basis: “So, my ...

Speaking recently to ESPN, the 65-year-old coach discussed his diagnosis, which came earlier this year, and how he’s used his own experiences to inspire players in the face of adversity. “Stuff ...

Abstract: This research proposes an optimized 3D Dense Convolutional Neural Network (CNN) architecture for high-precision prostate cancer volume segmentation in multi-parametric MRI (mpMRI), ...

Paws of War, a nonprofit that rescues dogs for veterans and first responders, reunited Sergeant Stormy and his dog Jasmine in early December Jasmine is now able to support Stormy as he undergoes ...

A University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their metabolism to thrive in bone tissue, offering a potential new treatment target for patients with ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...

Rubraca is now FDA-approved for BRCA mutation-associated mCRPC after prior androgen receptor-directed therapy, confirming its efficacy in the TRITON3 trial. The TRITON3 trial showed Rubraca ...